SG Americas Securities
IONS icon

SG Americas Securities’s Ionis Pharmaceuticals IONS Stock Holding History

SG Americas Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-200,000
Closed -$20K – 2793
2014
Q4 		$20K Hold
200,000
– – ﹤0.01% 3063
2014
Q3 		$600K Buy
+200,000
New +$7.09M ﹤0.01% 1380

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SG Americas Securities's IONS Position: Q2 2026 in Review

SG Americas Securities increased its Ionis Pharmaceuticals (IONS) stake by 18% in Q2 2026, buying an estimated $850K and bringing the position to 74,589 shares worth $5.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1031.

SG Americas Securities first reported a position in IONS in Q2 2013 and has held it in 45 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • SG Americas Securities held 74,589 shares of Ionis Pharmaceuticals worth $5.91M as of Q2 2026.
  • SG Americas Securities bought 11,294 Ionis Pharmaceuticals shares in Q2 2026, an estimated $850K.
  • Ionis Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1031 holding.
  • SG Americas Securities first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 45 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.